nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Dactinomycin—germ cell cancer	0.144	0.178	CbGbCtD
Mifepristone—ABCC1—Vinblastine—germ cell cancer	0.0904	0.112	CbGbCtD
Mifepristone—CYP3A7—Ifosfamide—germ cell cancer	0.0843	0.104	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0843	0.104	CbGbCtD
Mifepristone—ABCC1—Etoposide—germ cell cancer	0.0815	0.1	CbGbCtD
Mifepristone—CYP3A5—Ifosfamide—germ cell cancer	0.0632	0.0779	CbGbCtD
Mifepristone—ABCC1—Methotrexate—germ cell cancer	0.0538	0.0664	CbGbCtD
Mifepristone—ABCB1—Dactinomycin—germ cell cancer	0.0348	0.043	CbGbCtD
Mifepristone—CYP3A5—Etoposide—germ cell cancer	0.0302	0.0372	CbGbCtD
Mifepristone—CYP3A4—Ifosfamide—germ cell cancer	0.0246	0.0304	CbGbCtD
Mifepristone—ABCB1—Vinblastine—germ cell cancer	0.0218	0.0269	CbGbCtD
Mifepristone—CYP2D6—Vinblastine—germ cell cancer	0.0206	0.0254	CbGbCtD
Mifepristone—ABCB1—Cisplatin—germ cell cancer	0.02	0.0247	CbGbCtD
Mifepristone—ABCB1—Etoposide—germ cell cancer	0.0197	0.0242	CbGbCtD
Mifepristone—CYP3A4—Vinblastine—germ cell cancer	0.0131	0.0161	CbGbCtD
Mifepristone—ABCB1—Methotrexate—germ cell cancer	0.013	0.016	CbGbCtD
Mifepristone—CYP3A4—Etoposide—germ cell cancer	0.0118	0.0145	CbGbCtD
Mifepristone—AR—scrotum—germ cell cancer	0.00905	0.15	CbGeAlD
Mifepristone—AR—seminiferous tubule of testis—germ cell cancer	0.00704	0.117	CbGeAlD
Mifepristone—PGR—Nuclear Receptors—NR0B1—germ cell cancer	0.00281	0.0643	CbGpPWpGaD
Mifepristone—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00258	0.059	CbGpPWpGaD
Mifepristone—PGR—Ovarian Infertility Genes—INHA—germ cell cancer	0.00238	0.0544	CbGpPWpGaD
Mifepristone—PGR—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00222	0.0508	CbGpPWpGaD
Mifepristone—AR—Nuclear Receptors—NR0B1—germ cell cancer	0.00214	0.049	CbGpPWpGaD
Mifepristone—NR3C1—urine—germ cell cancer	0.00197	0.0326	CbGeAlD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.00185	0.0424	CbGpPWpGaD
Mifepristone—PGR—blood vessel—germ cell cancer	0.00185	0.0306	CbGeAlD
Mifepristone—AR—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00169	0.0387	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—GDF3—germ cell cancer	0.00169	0.0385	CbGpPWpGaD
Mifepristone—AR—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.00164	0.0376	CbGpPWpGaD
Mifepristone—NR3C1—Nuclear Receptors—NR0B1—germ cell cancer	0.00163	0.0372	CbGpPWpGaD
Mifepristone—CYP3A4—urine—germ cell cancer	0.00149	0.0247	CbGeAlD
Mifepristone—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00148	0.0339	CbGpPWpGaD
Mifepristone—CYP2D6—urine—germ cell cancer	0.00146	0.0243	CbGeAlD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00129	0.0294	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.00125	0.0285	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SALL4—germ cell cancer	0.00107	0.0244	CbGpPWpGaD
Mifepristone—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	0.00103	0.0235	CbGpPWpGaD
Mifepristone—CYP3A7—endocrine gland—germ cell cancer	0.000935	0.0155	CbGeAlD
Mifepristone—NR3C1—Endoderm Differentiation—SOX17—germ cell cancer	0.000924	0.0211	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—NANOG—germ cell cancer	0.000885	0.0202	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—POU5F1—germ cell cancer	0.000852	0.0195	CbGpPWpGaD
Mifepristone—PGR—decidua—germ cell cancer	0.00085	0.0141	CbGeAlD
Mifepristone—Pain in extremity—Ifosfamide—germ cell cancer	0.000811	0.00956	CcSEcCtD
Mifepristone—Rash maculo-papular—Etoposide—germ cell cancer	0.000802	0.00945	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.000797	0.00939	CcSEcCtD
Mifepristone—Haemoglobin—Vinblastine—germ cell cancer	0.000781	0.00921	CcSEcCtD
Mifepristone—Haemorrhage—Vinblastine—germ cell cancer	0.000777	0.00916	CcSEcCtD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—KLF4—germ cell cancer	0.000777	0.0178	CbGpPWpGaD
Mifepristone—NR3C1—neck—germ cell cancer	0.000763	0.0126	CbGeAlD
Mifepristone—PGR—uterus—germ cell cancer	0.000744	0.0123	CbGeAlD
Mifepristone—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000743	0.017	CbGpPWpGaD
Mifepristone—Hypokalaemia—Ifosfamide—germ cell cancer	0.000738	0.0087	CcSEcCtD
Mifepristone—Breast disorder—Ifosfamide—germ cell cancer	0.000733	0.00864	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.000731	0.00861	CcSEcCtD
Mifepristone—PGR—pituitary gland—germ cell cancer	0.00073	0.0121	CbGeAlD
Mifepristone—AR—telencephalon—germ cell cancer	0.000714	0.0118	CbGeAlD
Mifepristone—AR—skin of body—germ cell cancer	0.000682	0.0113	CbGeAlD
Mifepristone—ABCC1—telencephalon—germ cell cancer	0.000679	0.0112	CbGeAlD
Mifepristone—AR—decidua—germ cell cancer	0.000677	0.0112	CbGeAlD
Mifepristone—Haemoglobin—Bleomycin—germ cell cancer	0.00066	0.00778	CcSEcCtD
Mifepristone—NR3C1—trigeminal ganglion—germ cell cancer	0.000659	0.0109	CbGeAlD
Mifepristone—Haemorrhage—Bleomycin—germ cell cancer	0.000657	0.00774	CcSEcCtD
Mifepristone—PGR—adrenal gland—germ cell cancer	0.000652	0.0108	CbGeAlD
Mifepristone—ABCC1—decidua—germ cell cancer	0.000643	0.0107	CbGeAlD
Mifepristone—Hypokalaemia—Cisplatin—germ cell cancer	0.000636	0.0075	CcSEcCtD
Mifepristone—NR3C1—embryo—germ cell cancer	0.000636	0.0105	CbGeAlD
Mifepristone—Breast disorder—Cisplatin—germ cell cancer	0.000632	0.00745	CcSEcCtD
Mifepristone—Cramp muscle—Cisplatin—germ cell cancer	0.00063	0.00742	CcSEcCtD
Mifepristone—Ill-defined disorder—Vinblastine—germ cell cancer	0.000628	0.0074	CcSEcCtD
Mifepristone—Nasopharyngitis—Cisplatin—germ cell cancer	0.000625	0.00737	CcSEcCtD
Mifepristone—Infestation—Ifosfamide—germ cell cancer	0.000625	0.00736	CcSEcCtD
Mifepristone—Infestation NOS—Ifosfamide—germ cell cancer	0.000625	0.00736	CcSEcCtD
Mifepristone—Malaise—Vinblastine—germ cell cancer	0.00061	0.00719	CcSEcCtD
Mifepristone—PGR—female gonad—germ cell cancer	0.000608	0.0101	CbGeAlD
Mifepristone—AR—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000601	0.0137	CbGpPWpGaD
Mifepristone—AR—gonad—germ cell cancer	0.000596	0.00988	CbGeAlD
Mifepristone—AR—uterus—germ cell cancer	0.000592	0.00981	CbGeAlD
Mifepristone—Chills—Bleomycin—germ cell cancer	0.000589	0.00694	CcSEcCtD
Mifepristone—Hypertension—Vinblastine—germ cell cancer	0.000584	0.00688	CcSEcCtD
Mifepristone—NR3C1—brainstem—germ cell cancer	0.000583	0.00966	CbGeAlD
Mifepristone—AR—pituitary gland—germ cell cancer	0.000582	0.00964	CbGeAlD
Mifepristone—AR—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000578	0.0132	CbGpPWpGaD
Mifepristone—Cramp muscle—Etoposide—germ cell cancer	0.000577	0.0068	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000577	0.0068	CcSEcCtD
Mifepristone—ABCB1—blood vessel—germ cell cancer	0.000571	0.00946	CbGeAlD
Mifepristone—Discomfort—Vinblastine—germ cell cancer	0.000569	0.00671	CcSEcCtD
Mifepristone—NR3C1—eye—germ cell cancer	0.000568	0.0094	CbGeAlD
Mifepristone—PGR—endocrine gland—germ cell cancer	0.000566	0.00937	CbGeAlD
Mifepristone—Haemoglobin—Ifosfamide—germ cell cancer	0.000564	0.00664	CcSEcCtD
Mifepristone—ABCC1—uterus—germ cell cancer	0.000563	0.00932	CbGeAlD
Mifepristone—Haemorrhage—Ifosfamide—germ cell cancer	0.000561	0.00661	CcSEcCtD
Mifepristone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.00056	0.0128	CbGpPWpGaD
Mifepristone—PGR—head—germ cell cancer	0.000558	0.00925	CbGeAlD
Mifepristone—ABCC1—pituitary gland—germ cell cancer	0.000553	0.00915	CbGeAlD
Mifepristone—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000551	0.0065	CcSEcCtD
Mifepristone—Chills—Dactinomycin—germ cell cancer	0.00055	0.00647	CcSEcCtD
Mifepristone—PGR—testis—germ cell cancer	0.000539	0.00894	CbGeAlD
Mifepristone—Ill-defined disorder—Bleomycin—germ cell cancer	0.00053	0.00625	CcSEcCtD
Mifepristone—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000529	0.0121	CbGpPWpGaD
Mifepristone—Anorexia—Vinblastine—germ cell cancer	0.000527	0.0062	CcSEcCtD
Mifepristone—AR—adrenal gland—germ cell cancer	0.00052	0.00861	CbGeAlD
Mifepristone—NR3C1—telencephalon—germ cell cancer	0.000517	0.00857	CbGeAlD
Mifepristone—Malaise—Bleomycin—germ cell cancer	0.000515	0.00607	CcSEcCtD
Mifepristone—Angiopathy—Ifosfamide—germ cell cancer	0.000509	0.006	CcSEcCtD
Mifepristone—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000506	0.00596	CcSEcCtD
Mifepristone—Chills—Ifosfamide—germ cell cancer	0.000504	0.00593	CcSEcCtD
Mifepristone—AR—spinal cord—germ cell cancer	0.000501	0.00829	CbGeAlD
Mifepristone—PGR—cerebellum—germ cell cancer	0.000498	0.00825	CbGeAlD
Mifepristone—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000495	0.00583	CcSEcCtD
Mifepristone—NR3C1—skin of body—germ cell cancer	0.000494	0.00818	CbGeAlD
Mifepristone—Infestation NOS—Etoposide—germ cell cancer	0.000494	0.00582	CcSEcCtD
Mifepristone—Infestation—Etoposide—germ cell cancer	0.000494	0.00582	CcSEcCtD
Mifepristone—ABCC1—adrenal gland—germ cell cancer	0.000494	0.00818	CbGeAlD
Mifepristone—Mental disorder—Ifosfamide—germ cell cancer	0.000492	0.00579	CcSEcCtD
Mifepristone—NR3C1—decidua—germ cell cancer	0.00049	0.00813	CbGeAlD
Mifepristone—Malnutrition—Ifosfamide—germ cell cancer	0.000489	0.00576	CcSEcCtD
Mifepristone—Myalgia—Bleomycin—germ cell cancer	0.000487	0.00573	CcSEcCtD
Mifepristone—AR—female gonad—germ cell cancer	0.000485	0.00803	CbGeAlD
Mifepristone—Discomfort—Bleomycin—germ cell cancer	0.000481	0.00566	CcSEcCtD
Mifepristone—Malaise—Dactinomycin—germ cell cancer	0.000481	0.00566	CcSEcCtD
Mifepristone—Decreased appetite—Vinblastine—germ cell cancer	0.00048	0.00566	CcSEcCtD
Mifepristone—Connective tissue disorder—Cisplatin—germ cell cancer	0.000475	0.0056	CcSEcCtD
Mifepristone—NR3C1—Endoderm Differentiation—SOX2—germ cell cancer	0.000473	0.0108	CbGpPWpGaD
Mifepristone—Pain—Vinblastine—germ cell cancer	0.000472	0.00556	CcSEcCtD
Mifepristone—Constipation—Vinblastine—germ cell cancer	0.000472	0.00556	CcSEcCtD
Mifepristone—Oedema—Bleomycin—germ cell cancer	0.000467	0.0055	CcSEcCtD
Mifepristone—Infection—Bleomycin—germ cell cancer	0.000463	0.00546	CcSEcCtD
Mifepristone—ABCC1—female gonad—germ cell cancer	0.00046	0.00762	CbGeAlD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000456	0.0104	CbGpPWpGaD
Mifepristone—Feeling abnormal—Vinblastine—germ cell cancer	0.000455	0.00536	CcSEcCtD
Mifepristone—Myalgia—Dactinomycin—germ cell cancer	0.000454	0.00535	CcSEcCtD
Mifepristone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—germ cell cancer	0.000453	0.0104	CbGpPWpGaD
Mifepristone—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000453	0.00534	CcSEcCtD
Mifepristone—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000452	0.00532	CcSEcCtD
Mifepristone—AR—endocrine gland—germ cell cancer	0.000451	0.00747	CbGeAlD
Mifepristone—Discomfort—Dactinomycin—germ cell cancer	0.000448	0.00528	CcSEcCtD
Mifepristone—Angioedema—Ifosfamide—germ cell cancer	0.000446	0.00526	CcSEcCtD
Mifepristone—AR—head—germ cell cancer	0.000445	0.00737	CbGeAlD
Mifepristone—Anorexia—Bleomycin—germ cell cancer	0.000445	0.00524	CcSEcCtD
Mifepristone—Malaise—Ifosfamide—germ cell cancer	0.000441	0.00519	CcSEcCtD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000439	0.01	CbGpPWpGaD
Mifepristone—Abdominal pain—Vinblastine—germ cell cancer	0.000437	0.00514	CcSEcCtD
Mifepristone—Mediastinal disorder—Cisplatin—germ cell cancer	0.000436	0.00514	CcSEcCtD
Mifepristone—Hypotension—Bleomycin—germ cell cancer	0.000436	0.00514	CcSEcCtD
Mifepristone—Oedema—Dactinomycin—germ cell cancer	0.000435	0.00513	CcSEcCtD
Mifepristone—CYP2D6—brainstem—germ cell cancer	0.000434	0.00719	CbGeAlD
Mifepristone—Infection—Dactinomycin—germ cell cancer	0.000432	0.00509	CcSEcCtD
Mifepristone—NR3C1—gonad—germ cell cancer	0.000432	0.00715	CbGeAlD
Mifepristone—AR—testis—germ cell cancer	0.00043	0.00712	CbGeAlD
Mifepristone—NR3C1—uterus—germ cell cancer	0.000429	0.00711	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000425	0.00501	CcSEcCtD
Mifepristone—Hypertension—Ifosfamide—germ cell cancer	0.000422	0.00497	CcSEcCtD
Mifepristone—NR3C1—pituitary gland—germ cell cancer	0.000421	0.00698	CbGeAlD
Mifepristone—Malnutrition—Cisplatin—germ cell cancer	0.000421	0.00496	CcSEcCtD
Mifepristone—Dyspnoea—Bleomycin—germ cell cancer	0.000416	0.0049	CcSEcCtD
Mifepristone—Arthralgia—Ifosfamide—germ cell cancer	0.000416	0.0049	CcSEcCtD
Mifepristone—Myalgia—Ifosfamide—germ cell cancer	0.000416	0.0049	CcSEcCtD
Mifepristone—Anorexia—Dactinomycin—germ cell cancer	0.000415	0.00489	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000413	0.00487	CcSEcCtD
Mifepristone—Discomfort—Ifosfamide—germ cell cancer	0.000411	0.00484	CcSEcCtD
Mifepristone—ABCC1—testis—germ cell cancer	0.000408	0.00676	CbGeAlD
Mifepristone—Hypersensitivity—Vinblastine—germ cell cancer	0.000407	0.00479	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000407	0.00479	CcSEcCtD
Mifepristone—NR3C1—medulla oblongata—germ cell cancer	0.000407	0.00674	CbGeAlD
Mifepristone—Decreased appetite—Bleomycin—germ cell cancer	0.000406	0.00478	CcSEcCtD
Mifepristone—Muscle spasms—Cisplatin—germ cell cancer	0.000405	0.00477	CcSEcCtD
Mifepristone—PGR—brain—germ cell cancer	0.000405	0.0067	CbGeAlD
Mifepristone—Angiopathy—Etoposide—germ cell cancer	0.000402	0.00474	CcSEcCtD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	0.000402	0.00918	CbGpPWpGaD
Mifepristone—Mediastinal disorder—Etoposide—germ cell cancer	0.000399	0.00471	CcSEcCtD
Mifepristone—Pain—Bleomycin—germ cell cancer	0.000399	0.0047	CcSEcCtD
Mifepristone—Oedema—Ifosfamide—germ cell cancer	0.000399	0.0047	CcSEcCtD
Mifepristone—Chills—Etoposide—germ cell cancer	0.000398	0.00469	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000396	0.00467	CcSEcCtD
Mifepristone—Asthenia—Vinblastine—germ cell cancer	0.000396	0.00467	CcSEcCtD
Mifepristone—Infection—Ifosfamide—germ cell cancer	0.000396	0.00467	CcSEcCtD
Mifepristone—PGR—lymph node—germ cell cancer	0.000391	0.00648	CbGeAlD
Mifepristone—Nervous system disorder—Ifosfamide—germ cell cancer	0.000391	0.00461	CcSEcCtD
Mifepristone—Ill-defined disorder—Cisplatin—germ cell cancer	0.000391	0.0046	CcSEcCtD
Mifepristone—Skin disorder—Ifosfamide—germ cell cancer	0.000387	0.00456	CcSEcCtD
Mifepristone—CYP2D6—telencephalon—germ cell cancer	0.000385	0.00638	CbGeAlD
Mifepristone—Feeling abnormal—Bleomycin—germ cell cancer	0.000384	0.00453	CcSEcCtD
Mifepristone—PGR—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000384	0.00878	CbGpPWpGaD
Mifepristone—Anorexia—Ifosfamide—germ cell cancer	0.00038	0.00448	CcSEcCtD
Mifepristone—Malaise—Cisplatin—germ cell cancer	0.00038	0.00447	CcSEcCtD
Mifepristone—Decreased appetite—Dactinomycin—germ cell cancer	0.000378	0.00446	CcSEcCtD
Mifepristone—Diarrhoea—Vinblastine—germ cell cancer	0.000378	0.00445	CcSEcCtD
Mifepristone—ABCC1—cerebellum—germ cell cancer	0.000377	0.00625	CbGeAlD
Mifepristone—NR3C1—adrenal gland—germ cell cancer	0.000376	0.00624	CbGeAlD
Mifepristone—Fatigue—Dactinomycin—germ cell cancer	0.000375	0.00442	CcSEcCtD
Mifepristone—Back pain—Etoposide—germ cell cancer	0.000373	0.0044	CcSEcCtD
Mifepristone—Hypotension—Ifosfamide—germ cell cancer	0.000373	0.00439	CcSEcCtD
Mifepristone—Pain—Dactinomycin—germ cell cancer	0.000372	0.00438	CcSEcCtD
Mifepristone—NR3C1—midbrain—germ cell cancer	0.000372	0.00616	CbGeAlD
Mifepristone—Muscle spasms—Etoposide—germ cell cancer	0.000371	0.00437	CcSEcCtD
Mifepristone—Urticaria—Bleomycin—germ cell cancer	0.000371	0.00437	CcSEcCtD
Mifepristone—Body temperature increased—Bleomycin—germ cell cancer	0.000369	0.00434	CcSEcCtD
Mifepristone—Dizziness—Vinblastine—germ cell cancer	0.000365	0.0043	CcSEcCtD
Mifepristone—NR3C1—bone marrow—germ cell cancer	0.000364	0.00603	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000363	0.00428	CcSEcCtD
Mifepristone—NR3C1—spinal cord—germ cell cancer	0.000363	0.00601	CbGeAlD
Mifepristone—Myalgia—Cisplatin—germ cell cancer	0.000359	0.00422	CcSEcCtD
Mifepristone—Feeling abnormal—Dactinomycin—germ cell cancer	0.000359	0.00422	CcSEcCtD
Mifepristone—Ill-defined disorder—Etoposide—germ cell cancer	0.000358	0.00422	CcSEcCtD
Mifepristone—Anxiety—Cisplatin—germ cell cancer	0.000357	0.00421	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000356	0.0042	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000356	0.00419	CcSEcCtD
Mifepristone—Dyspnoea—Ifosfamide—germ cell cancer	0.000355	0.00419	CcSEcCtD
Mifepristone—Somnolence—Ifosfamide—germ cell cancer	0.000354	0.00418	CcSEcCtD
Mifepristone—Discomfort—Cisplatin—germ cell cancer	0.000354	0.00417	CcSEcCtD
Mifepristone—CYP3A5—female gonad—germ cell cancer	0.000354	0.00586	CbGeAlD
Mifepristone—ABCB1—trigeminal ganglion—germ cell cancer	0.000353	0.00584	CbGeAlD
Mifepristone—Vomiting—Vinblastine—germ cell cancer	0.000351	0.00414	CcSEcCtD
Mifepristone—NR3C1—female gonad—germ cell cancer	0.000351	0.00581	CbGeAlD
Mifepristone—Malaise—Etoposide—germ cell cancer	0.000348	0.0041	CcSEcCtD
Mifepristone—Breast disorder—Methotrexate—germ cell cancer	0.000347	0.00409	CcSEcCtD
Mifepristone—Decreased appetite—Ifosfamide—germ cell cancer	0.000347	0.00408	CcSEcCtD
Mifepristone—Headache—Vinblastine—germ cell cancer	0.000346	0.00408	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000346	0.00407	CcSEcCtD
Mifepristone—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000346	0.0079	CbGpPWpGaD
Mifepristone—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000344	0.00406	CcSEcCtD
Mifepristone—Body temperature increased—Dactinomycin—germ cell cancer	0.000344	0.00405	CcSEcCtD
Mifepristone—Abdominal pain—Dactinomycin—germ cell cancer	0.000344	0.00405	CcSEcCtD
Mifepristone—Fatigue—Ifosfamide—germ cell cancer	0.000344	0.00405	CcSEcCtD
Mifepristone—Oedema—Cisplatin—germ cell cancer	0.000344	0.00405	CcSEcCtD
Mifepristone—Hypersensitivity—Bleomycin—germ cell cancer	0.000344	0.00405	CcSEcCtD
Mifepristone—Infection—Cisplatin—germ cell cancer	0.000341	0.00402	CcSEcCtD
Mifepristone—Pain—Ifosfamide—germ cell cancer	0.000341	0.00402	CcSEcCtD
Mifepristone—Constipation—Ifosfamide—germ cell cancer	0.000341	0.00402	CcSEcCtD
Mifepristone—ABCB1—embryo—germ cell cancer	0.000341	0.00564	CbGeAlD
Mifepristone—Nervous system disorder—Cisplatin—germ cell cancer	0.000337	0.00397	CcSEcCtD
Mifepristone—Asthenia—Bleomycin—germ cell cancer	0.000335	0.00394	CcSEcCtD
Mifepristone—Skin disorder—Cisplatin—germ cell cancer	0.000334	0.00393	CcSEcCtD
Mifepristone—Hypertension—Etoposide—germ cell cancer	0.000333	0.00392	CcSEcCtD
Mifepristone—NR3C1—Circadian Clock—AVP—germ cell cancer	0.00033	0.00755	CbGpPWpGaD
Mifepristone—Pruritus—Bleomycin—germ cell cancer	0.00033	0.00389	CcSEcCtD
Mifepristone—CYP3A5—endocrine gland—germ cell cancer	0.000329	0.00545	CbGeAlD
Mifepristone—Feeling abnormal—Ifosfamide—germ cell cancer	0.000329	0.00387	CcSEcCtD
Mifepristone—Nausea—Vinblastine—germ cell cancer	0.000328	0.00387	CcSEcCtD
Mifepristone—Anorexia—Cisplatin—germ cell cancer	0.000328	0.00386	CcSEcCtD
Mifepristone—NR3C1—endocrine gland—germ cell cancer	0.000326	0.00541	CbGeAlD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000326	0.00384	CcSEcCtD
Mifepristone—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000326	0.00384	CcSEcCtD
Mifepristone—Discomfort—Etoposide—germ cell cancer	0.000325	0.00382	CcSEcCtD
Mifepristone—AR—brain—germ cell cancer	0.000322	0.00534	CbGeAlD
Mifepristone—NR3C1—head—germ cell cancer	0.000322	0.00534	CbGeAlD
Mifepristone—Hypotension—Cisplatin—germ cell cancer	0.000321	0.00378	CcSEcCtD
Mifepristone—AR—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000321	0.00733	CbGpPWpGaD
Mifepristone—Hypersensitivity—Dactinomycin—germ cell cancer	0.000321	0.00378	CcSEcCtD
Mifepristone—Urticaria—Ifosfamide—germ cell cancer	0.000317	0.00373	CcSEcCtD
Mifepristone—PGR—Signaling by ERBB4—FGF4—germ cell cancer	0.000315	0.00721	CbGpPWpGaD
Mifepristone—Body temperature increased—Ifosfamide—germ cell cancer	0.000315	0.00371	CcSEcCtD
Mifepristone—Abdominal pain—Ifosfamide—germ cell cancer	0.000315	0.00371	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000313	0.00369	CcSEcCtD
Mifepristone—Infection—Etoposide—germ cell cancer	0.000313	0.00369	CcSEcCtD
Mifepristone—Asthenia—Dactinomycin—germ cell cancer	0.000312	0.00368	CcSEcCtD
Mifepristone—AR—lymph node—germ cell cancer	0.000312	0.00516	CbGeAlD
Mifepristone—NR3C1—testis—germ cell cancer	0.000311	0.00516	CbGeAlD
Mifepristone—Dyspnoea—Cisplatin—germ cell cancer	0.000306	0.00361	CcSEcCtD
Mifepristone—ABCC1—brain—germ cell cancer	0.000306	0.00507	CbGeAlD
Mifepristone—Skin disorder—Etoposide—germ cell cancer	0.000306	0.0036	CcSEcCtD
Mifepristone—ABCB1—retina—germ cell cancer	0.000301	0.00499	CbGeAlD
Mifepristone—Anorexia—Etoposide—germ cell cancer	0.0003	0.00354	CcSEcCtD
Mifepristone—Decreased appetite—Cisplatin—germ cell cancer	0.000299	0.00352	CcSEcCtD
Mifepristone—Diarrhoea—Dactinomycin—germ cell cancer	0.000298	0.00351	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000297	0.0035	CcSEcCtD
Mifepristone—Vomiting—Bleomycin—germ cell cancer	0.000297	0.00349	CcSEcCtD
Mifepristone—ABCC1—lymph node—germ cell cancer	0.000296	0.0049	CbGeAlD
Mifepristone—Infestation—Methotrexate—germ cell cancer	0.000296	0.00348	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—germ cell cancer	0.000296	0.00348	CcSEcCtD
Mifepristone—Hypotension—Etoposide—germ cell cancer	0.000294	0.00347	CcSEcCtD
Mifepristone—Rash—Bleomycin—germ cell cancer	0.000294	0.00347	CcSEcCtD
Mifepristone—Pain—Cisplatin—germ cell cancer	0.000294	0.00346	CcSEcCtD
Mifepristone—Dermatitis—Bleomycin—germ cell cancer	0.000294	0.00346	CcSEcCtD
Mifepristone—Hypersensitivity—Ifosfamide—germ cell cancer	0.000294	0.00346	CcSEcCtD
Mifepristone—AR—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000293	0.00669	CbGpPWpGaD
Mifepristone—NR3C1—cerebellum—germ cell cancer	0.000287	0.00476	CbGeAlD
Mifepristone—Asthenia—Ifosfamide—germ cell cancer	0.000286	0.00337	CcSEcCtD
Mifepristone—Feeling abnormal—Cisplatin—germ cell cancer	0.000283	0.00334	CcSEcCtD
Mifepristone—Pruritus—Ifosfamide—germ cell cancer	0.000282	0.00332	CcSEcCtD
Mifepristone—Dyspnoea—Etoposide—germ cell cancer	0.000281	0.00331	CcSEcCtD
Mifepristone—Somnolence—Etoposide—germ cell cancer	0.00028	0.0033	CcSEcCtD
Mifepristone—Nausea—Bleomycin—germ cell cancer	0.000277	0.00326	CcSEcCtD
Mifepristone—ABCB1—telencephalon—germ cell cancer	0.000277	0.00459	CbGeAlD
Mifepristone—Vomiting—Dactinomycin—germ cell cancer	0.000277	0.00326	CcSEcCtD
Mifepristone—Rash—Dactinomycin—germ cell cancer	0.000274	0.00323	CcSEcCtD
Mifepristone—Decreased appetite—Etoposide—germ cell cancer	0.000274	0.00322	CcSEcCtD
Mifepristone—Diarrhoea—Ifosfamide—germ cell cancer	0.000273	0.00321	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000272	0.0032	CcSEcCtD
Mifepristone—Body temperature increased—Cisplatin—germ cell cancer	0.000272	0.0032	CcSEcCtD
Mifepristone—Fatigue—Etoposide—germ cell cancer	0.000271	0.0032	CcSEcCtD
Mifepristone—Constipation—Etoposide—germ cell cancer	0.000269	0.00317	CcSEcCtD
Mifepristone—Pain—Etoposide—germ cell cancer	0.000269	0.00317	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—germ cell cancer	0.000267	0.00314	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—germ cell cancer	0.000265	0.00313	CcSEcCtD
Mifepristone—Dizziness—Ifosfamide—germ cell cancer	0.000264	0.00311	CcSEcCtD
Mifepristone—ABCB1—decidua—germ cell cancer	0.000263	0.00435	CbGeAlD
Mifepristone—CYP2D6—female gonad—germ cell cancer	0.000261	0.00433	CbGeAlD
Mifepristone—Feeling abnormal—Etoposide—germ cell cancer	0.00026	0.00306	CcSEcCtD
Mifepristone—PGR—Signaling by ERBB4—KITLG—germ cell cancer	0.000259	0.00593	CbGpPWpGaD
Mifepristone—Nausea—Dactinomycin—germ cell cancer	0.000258	0.00304	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—germ cell cancer	0.000258	0.00303	CcSEcCtD
Mifepristone—Vomiting—Ifosfamide—germ cell cancer	0.000254	0.00299	CcSEcCtD
Mifepristone—Hypersensitivity—Cisplatin—germ cell cancer	0.000253	0.00298	CcSEcCtD
Mifepristone—Rash—Ifosfamide—germ cell cancer	0.000251	0.00296	CcSEcCtD
Mifepristone—Dermatitis—Ifosfamide—germ cell cancer	0.000251	0.00296	CcSEcCtD
Mifepristone—Urticaria—Etoposide—germ cell cancer	0.00025	0.00295	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—germ cell cancer	0.000249	0.00293	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—germ cell cancer	0.000249	0.00293	CcSEcCtD
Mifepristone—CYP3A4—endocrine gland—germ cell cancer	0.000247	0.00409	CbGeAlD
Mifepristone—Asthenia—Cisplatin—germ cell cancer	0.000247	0.00291	CcSEcCtD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000243	0.00556	CbGpPWpGaD
Mifepristone—CYP2D6—endocrine gland—germ cell cancer	0.000243	0.00402	CbGeAlD
Mifepristone—Angiopathy—Methotrexate—germ cell cancer	0.000241	0.00284	CcSEcCtD
Mifepristone—CYP2D6—head—germ cell cancer	0.00024	0.00397	CbGeAlD
Mifepristone—Mediastinal disorder—Methotrexate—germ cell cancer	0.000239	0.00282	CcSEcCtD
Mifepristone—Chills—Methotrexate—germ cell cancer	0.000238	0.00281	CcSEcCtD
Mifepristone—Nausea—Ifosfamide—germ cell cancer	0.000237	0.00279	CcSEcCtD
Mifepristone—Diarrhoea—Cisplatin—germ cell cancer	0.000235	0.00277	CcSEcCtD
Mifepristone—NR3C1—brain—germ cell cancer	0.000234	0.00387	CbGeAlD
Mifepristone—Mental disorder—Methotrexate—germ cell cancer	0.000233	0.00274	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—germ cell cancer	0.000232	0.00273	CcSEcCtD
Mifepristone—CYP2D6—testis—germ cell cancer	0.000232	0.00384	CbGeAlD
Mifepristone—ABCB1—gonad—germ cell cancer	0.000231	0.00383	CbGeAlD
Mifepristone—Malnutrition—Methotrexate—germ cell cancer	0.000231	0.00272	CcSEcCtD
Mifepristone—ABCB1—uterus—germ cell cancer	0.00023	0.00381	CbGeAlD
Mifepristone—Asthenia—Etoposide—germ cell cancer	0.000226	0.00266	CcSEcCtD
Mifepristone—NR3C1—lymph node—germ cell cancer	0.000226	0.00374	CbGeAlD
Mifepristone—ABCB1—pituitary gland—germ cell cancer	0.000226	0.00374	CbGeAlD
Mifepristone—Back pain—Methotrexate—germ cell cancer	0.000224	0.00263	CcSEcCtD
Mifepristone—Pruritus—Etoposide—germ cell cancer	0.000223	0.00262	CcSEcCtD
Mifepristone—NR3C1—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000222	0.00508	CbGpPWpGaD
Mifepristone—Vomiting—Cisplatin—germ cell cancer	0.000219	0.00257	CcSEcCtD
Mifepristone—ABCB1—medulla oblongata—germ cell cancer	0.000218	0.00361	CbGeAlD
Mifepristone—Rash—Cisplatin—germ cell cancer	0.000217	0.00255	CcSEcCtD
Mifepristone—Dermatitis—Cisplatin—germ cell cancer	0.000217	0.00255	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—germ cell cancer	0.000215	0.00254	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—germ cell cancer	0.000214	0.00253	CcSEcCtD
Mifepristone—CYP2D6—cerebellum—germ cell cancer	0.000214	0.00354	CbGeAlD
Mifepristone—Malaise—Methotrexate—germ cell cancer	0.000208	0.00246	CcSEcCtD
Mifepristone—Dizziness—Etoposide—germ cell cancer	0.000208	0.00245	CcSEcCtD
Mifepristone—AR—Nongenotropic Androgen signaling—HRAS—germ cell cancer	0.000208	0.00475	CbGpPWpGaD
Mifepristone—Nausea—Cisplatin—germ cell cancer	0.000204	0.00241	CcSEcCtD
Mifepristone—ABCB1—adrenal gland—germ cell cancer	0.000202	0.00334	CbGeAlD
Mifepristone—Vomiting—Etoposide—germ cell cancer	0.0002	0.00236	CcSEcCtD
Mifepristone—ABCB1—midbrain—germ cell cancer	0.000199	0.0033	CbGeAlD
Mifepristone—Rash—Etoposide—germ cell cancer	0.000199	0.00234	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—germ cell cancer	0.000198	0.00234	CcSEcCtD
Mifepristone—Headache—Etoposide—germ cell cancer	0.000197	0.00232	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—germ cell cancer	0.000197	0.00232	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—germ cell cancer	0.000197	0.00232	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000195	0.0023	CcSEcCtD
Mifepristone—ABCB1—bone marrow—germ cell cancer	0.000195	0.00323	CbGeAlD
Mifepristone—Discomfort—Methotrexate—germ cell cancer	0.000194	0.00229	CcSEcCtD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	0.000194	0.00444	CbGpPWpGaD
Mifepristone—ABCB1—spinal cord—germ cell cancer	0.000194	0.00322	CbGeAlD
Mifepristone—PGR—Signaling by ERBB4—FGFR3—germ cell cancer	0.000193	0.0044	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000189	0.00432	CbGpPWpGaD
Mifepristone—ABCB1—female gonad—germ cell cancer	0.000188	0.00311	CbGeAlD
Mifepristone—Infection—Methotrexate—germ cell cancer	0.000187	0.00221	CcSEcCtD
Mifepristone—Nausea—Etoposide—germ cell cancer	0.000187	0.0022	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—germ cell cancer	0.000185	0.00218	CcSEcCtD
Mifepristone—PGR—Gene Expression—NR0B1—germ cell cancer	0.000185	0.00423	CbGpPWpGaD
Mifepristone—Skin disorder—Methotrexate—germ cell cancer	0.000183	0.00216	CcSEcCtD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000181	0.00414	CbGpPWpGaD
Mifepristone—Anorexia—Methotrexate—germ cell cancer	0.00018	0.00212	CcSEcCtD
Mifepristone—PGR—Signaling by ERBB4—KIT—germ cell cancer	0.000177	0.00404	CbGpPWpGaD
Mifepristone—Hypotension—Methotrexate—germ cell cancer	0.000176	0.00208	CcSEcCtD
Mifepristone—ABCB1—endocrine gland—germ cell cancer	0.000175	0.00289	CbGeAlD
Mifepristone—CYP2D6—brain—germ cell cancer	0.000174	0.00288	CbGeAlD
Mifepristone—ABCB1—head—germ cell cancer	0.000173	0.00286	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000172	0.00202	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—germ cell cancer	0.000171	0.00201	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—germ cell cancer	0.000168	0.00198	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—germ cell cancer	0.000168	0.00198	CcSEcCtD
Mifepristone—ABCB1—testis—germ cell cancer	0.000167	0.00276	CbGeAlD
Mifepristone—Decreased appetite—Methotrexate—germ cell cancer	0.000164	0.00193	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000163	0.00192	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—germ cell cancer	0.000163	0.00192	CcSEcCtD
Mifepristone—Pain—Methotrexate—germ cell cancer	0.000161	0.0019	CcSEcCtD
Mifepristone—PGR—Gene Expression—DNMT3L—germ cell cancer	0.00016	0.00367	CbGpPWpGaD
Mifepristone—Feeling abnormal—Methotrexate—germ cell cancer	0.000155	0.00183	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000154	0.00182	CcSEcCtD
Mifepristone—ABCB1—cerebellum—germ cell cancer	0.000154	0.00255	CbGeAlD
Mifepristone—Urticaria—Methotrexate—germ cell cancer	0.00015	0.00177	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—germ cell cancer	0.000149	0.00176	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—germ cell cancer	0.000149	0.00176	CcSEcCtD
Mifepristone—PGR—Gene Expression—RARS—germ cell cancer	0.000149	0.00341	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000143	0.00328	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NR0B1—germ cell cancer	0.000141	0.00322	CbGpPWpGaD
Mifepristone—Hypersensitivity—Methotrexate—germ cell cancer	0.000139	0.00164	CcSEcCtD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000136	0.00311	CbGpPWpGaD
Mifepristone—Asthenia—Methotrexate—germ cell cancer	0.000135	0.00159	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—germ cell cancer	0.000133	0.00157	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—germ cell cancer	0.000129	0.00152	CcSEcCtD
Mifepristone—ABCB1—brain—germ cell cancer	0.000125	0.00207	CbGeAlD
Mifepristone—Dizziness—Methotrexate—germ cell cancer	0.000125	0.00147	CcSEcCtD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	0.000124	0.00283	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	0.000123	0.0028	CbGpPWpGaD
Mifepristone—AR—Gene Expression—DNMT3L—germ cell cancer	0.000122	0.00279	CbGpPWpGaD
Mifepristone—ABCB1—lymph node—germ cell cancer	0.000121	0.002	CbGeAlD
Mifepristone—Vomiting—Methotrexate—germ cell cancer	0.00012	0.00141	CcSEcCtD
Mifepristone—Rash—Methotrexate—germ cell cancer	0.000119	0.0014	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—germ cell cancer	0.000119	0.0014	CcSEcCtD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000119	0.00271	CbGpPWpGaD
Mifepristone—Headache—Methotrexate—germ cell cancer	0.000118	0.00139	CcSEcCtD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000117	0.00267	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RARS—germ cell cancer	0.000114	0.0026	CbGpPWpGaD
Mifepristone—Nausea—Methotrexate—germ cell cancer	0.000112	0.00132	CcSEcCtD
Mifepristone—NR3C1—Gene Expression—NR0B1—germ cell cancer	0.000107	0.00244	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MYC—germ cell cancer	0.000105	0.00239	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.0001	0.00229	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	9.31e-05	0.00213	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—DNMT3L—germ cell cancer	9.27e-05	0.00212	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.62e-05	0.00197	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RARS—germ cell cancer	8.62e-05	0.00197	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—germ cell cancer	8.59e-05	0.00196	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—HRAS—germ cell cancer	7.64e-05	0.00175	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	7.57e-05	0.00173	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	7.47e-05	0.00171	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	7.45e-05	0.0017	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SLC2A3—germ cell cancer	6.63e-05	0.00152	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	6.18e-05	0.00141	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	6.12e-05	0.0014	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.64e-05	0.00129	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—H2AFZ—germ cell cancer	5.61e-05	0.00128	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.56e-05	0.00127	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC2A3—germ cell cancer	5.55e-05	0.00127	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC22A3—germ cell cancer	5.47e-05	0.00125	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.47e-05	0.00125	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	5.07e-05	0.00116	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC2A3—germ cell cancer	4.84e-05	0.00111	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—OXT—germ cell cancer	4.79e-05	0.00109	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC22A3—germ cell cancer	4.77e-05	0.00109	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CRABP1—germ cell cancer	4.46e-05	0.00102	CbGpPWpGaD
Mifepristone—AR—Gene Expression—H2AFZ—germ cell cancer	4.28e-05	0.000978	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGF4—germ cell cancer	4.09e-05	0.000934	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—germ cell cancer	4.03e-05	0.000921	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CRABP1—germ cell cancer	3.89e-05	0.000889	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGF4—germ cell cancer	3.81e-05	0.000871	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—H2AFZ—germ cell cancer	3.65e-05	0.000834	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC2A3—germ cell cancer	3.5e-05	0.000801	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC22A3—germ cell cancer	3.45e-05	0.000789	CbGpPWpGaD
Mifepristone—ABCC1—Disease—H2AFZ—germ cell cancer	3.4e-05	0.000778	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KITLG—germ cell cancer	3.36e-05	0.000768	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AVP—germ cell cancer	3.28e-05	0.00075	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—H2AFZ—germ cell cancer	3.24e-05	0.000742	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KITLG—germ cell cancer	3.13e-05	0.000715	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—germ cell cancer	3.07e-05	0.000701	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CRABP1—germ cell cancer	2.81e-05	0.000643	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.64e-05	0.000604	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.6e-05	0.000595	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.6e-05	0.000595	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.52e-05	0.000575	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGFR3—germ cell cancer	2.49e-05	0.00057	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC2A3—germ cell cancer	2.49e-05	0.000569	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC22A3—germ cell cancer	2.45e-05	0.000561	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—germ cell cancer	2.33e-05	0.000532	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGFR3—germ cell cancer	2.33e-05	0.000532	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KIT—germ cell cancer	2.29e-05	0.000524	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KIT—germ cell cancer	2.14e-05	0.000488	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CRABP1—germ cell cancer	2.12e-05	0.000485	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.07e-05	0.000473	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CRABP1—germ cell cancer	2e-05	0.000457	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—germ cell cancer	1.94e-05	0.000443	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.63e-05	0.000372	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.6e-05	0.000367	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—germ cell cancer	1.48e-05	0.000338	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.31e-05	0.000299	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—germ cell cancer	1.26e-05	0.000288	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—germ cell cancer	1.17e-05	0.000269	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—germ cell cancer	1.12e-05	0.000256	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—germ cell cancer	1.04e-05	0.000237	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—germ cell cancer	9.9e-06	0.000226	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—germ cell cancer	9.23e-06	0.000211	CbGpPWpGaD
